{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:46Z","timestamp":1791919006918,"version":"4.3.4"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3413","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T14:57:16Z","timestamp":1427900236000},"page":"819-822","source":"Crossref","is-referenced-by-count":12,"title":["The Development of Fulminant Type 1 Diabetes during Chemotherapy for Rectal Cancer"],"prefix":"10.2169","volume":"54","author":[{"given":"Junichiro","family":"Adachi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ohkubo Hospital, Japan"},{"name":"Department of Diabetes and Endocrinology, Yokohama City Minato Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiyo","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Yokohama City Minato Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Gotyo","sequence":"additional","affiliation":[{"name":"Diabetes Center, Ebina General Hospital, Japan"},{"name":"Department of Diabetes and Endocrinology, Yokohama City Minato Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Yokohama City Minato Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 3: 36-45, 2007.","DOI":"10.1038\/ncpendmet0351"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated-cell failure in fulminant type 1 diabetes. Diabetes 58: 2285-2291, 2009.","DOI":"10.2337\/db09-0091"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Imagawa A, Hanafusa T. Fulminant type 1 diabetes: an important subtype in East Asia. Diabetes Metab Res Rev 27: 959-964, 2011.","DOI":"10.1002\/dmrr.1236"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25: 995-1001, 2002.","DOI":"10.2337\/diacare.25.6.995"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48: 294-300, 2005.","DOI":"10.1007\/s00125-004-1626-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tsutsumi C, Imagawa A, Ikegami H, Makino H, Kobayashi T, Hanafusa T; Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Class II HLA genotype in fulminant type 1 diabetes: a nationwide survey with reference to glutamic acid decarboxylase antibodies. J Diabetes Investig 3: 62-69, 2012.","DOI":"10.1111\/j.2040-1124.2011.00139.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kawasaki E, Imagawa A, Makino H, et al. Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 31: 1608-1610, 2008.","DOI":"10.2337\/dc08-0280"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kotani R, Nagata M, Imagawa A, et al. T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes. Diabetologia 47: 1285-1291, 2004.","DOI":"10.1007\/s00125-004-1441-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Imagawa A, Hanafusa T, Makino H, Miyagawa JI, Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia 48: 290-293, 2005.","DOI":"10.1007\/s00125-004-1624-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tanaka S, Nishida Y, Aida K, et al. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes. Endocr J 60: 837-845, 2013.","DOI":"10.1507\/endocrj.EJ13-0222"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fabris P, Betterle C, Floreani A, et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 340: 548, 1992.","DOI":"10.1016\/0140-6736(92)91744-S"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Uto H, Matsuoka H, Murata M, et al. A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract 49: 101-106, 2000.","DOI":"10.1016\/S0168-8227(00)00143-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Diana J, Simoni Y, Furio L, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19: 65-73, 2012.","DOI":"10.1038\/nm.3042"},{"key":"14","unstructured":"14. Yanase K, Nakamura Y, Yasui T, Kakimoto M, Yanase O. Fulminant type 1 diabetes mellitus onset during postoperative chemotherapy for breast cancer. Tonyobyo (Journal of the Japan Diabetes Society) 53: 107-111, 2010 (in Japanese)."},{"key":"15","unstructured":"15. Yonekura K, Basaki Y, Chikahisa L, et al. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin Cancer Res 5: 2185-2191, 1999."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338, 2003.","DOI":"10.1038\/nrc1074"},{"key":"17","unstructured":"17. Hoff PM, Pazdur R. UFT plus oral leucovorin: a new oral treatment for colorectal cancer. Oncologist 3: 155-164, 1998."},{"key":"18","unstructured":"18. Eisenthal A, Eytan K, Brazowski E, Katz BZ, Shirazi I, Skornick Y. Effects of 5-fluorouracil on human mitogen-activated peripheral blood lymphocytes from healthy individuals. Anticancer Res 28: 3785-3791, 2008."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lu H, Klein RS, Schwartz EL. Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap. Clin Cancer Res 15: 5136-5144, 2009.","DOI":"10.1158\/1078-0432.CCR-08-3203"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Toi M, Rahman MA, Bando H, Chow Louis WC. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol 6: 158-166, 2005.","DOI":"10.1016\/S1470-2045(05)01766-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Toyoda Y, Tabata S, Kishi J, et al. Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol 66: 560-568, 2014.","DOI":"10.1002\/art.38263"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:22:28Z","timestamp":1498206148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/7\/54_54.3413\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3413","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}